Reply to the Editor  by Wada, Shinichi et al.
nulation remains widely accepted and pop-
ularized for reasons that remain unclear.
This is despite the fact that it is the most
“physiologic” approach in establishing car-
diopulmonary bypass in acute type A aortic
dissection. We have been using this tech-
nique exclusively since 1995 for the rea-
sons outlined by Dr Wada and associates.
However, we would like to share additional
valuable comments that our experience has
demonstrated.
Although placement of the aortic cannula
through the aortic valve into the true lumen is
desirable, it is not essential. In some cases of
cardiomegaly we found that the cannula was
too short to traverse the aortic valve. The tip
was therefore guided into the left ventricular
outflow tract under transesophageal echocar-
diography. We encountered no compromise
in perfusion pressures, flow rates, or ventric-
ular distension. Furthermore, although Dr
Wada and colleagues suggest that the tech-
nique is not practical after previous cardiac
surgery, our experience is to the contrary. We
recently used the transapical approach in a
patient who presented with recurrent type A
aortic dissection some years after his initial
presentation. The dissection flap involved
both femoral arteries and neck vessels, pre-
cluding all other sites for extrathoracic can-
nulation. The left ventricular apex was easily
exposed through a small left thoracotomy
and a 21F Bio-Medicus cannula (Medtronic,
Minneapolis, Minn) introduced through a
stab incision. The presence of such patients
with no option for extrathoracic cannulation
because of extensive dissection is not un-
common, and they would otherwise be
denied surgery. However, perfusion of
the true lumen can be ensured with the
transapical approach.
The theoretic disadvantages to the ap-
proach include potential problems with the
stab incision repair. Our arterial cannula is
designed for percutaneous femoral cannu-
lation and has a rigid sharp introducer. Our
stab incision, which measures less than
4 mm, is not full thickness because the myo-
cardium is split along the fibers by the
cannula rather than cut by a knife. In our
experience the size of the wound is similar
to that when an apical vent is used for
conventional aortic valve replacement. Be-
cause of the small wound size, we do not
routinely use pledgets for repair but place a
horizontal mattress 4-0 polypropylene su-
ture with an over-and-over running suture.
To date we have encountered no technical
difficulty with the repair site.
In conclusion, our experience supports
the use of transapical cannulation as the
method of choice for arterial inflow in type A
dissection. We strongly advocate its routine
use and are grateful to Dr Wada and col-
leagues for confirming it in their large series.
Rajwinder S. Jutley, MD, MRCS
Nicola Masala, MD
A. W. Sosnowski, MD, FRCS
Department of Cardiac Surgery
Glenfield Hospital
Leicester, United Kingdom
References
1. Wada S, Yamamoto S, Honda J, Hiramoto A,
Wada H, Hosoda Y. Transapical aortic can-
nulation for cardiopulmonary bypass in type
A aortic dissection operations. J Thorac Car-
diovasc Surg. 2006;132:369-72.
2. Zwart HH, Kralios A, Collan R, Kolff WJ.
Transarterial closed-chest left ventricular
(TaCLV) bypass. Trans Am Soc Artif Intern
Organs. 1969;15:386-90.
doi:10.1016/j.jtcvs.2006.09.117
Reply to the Editor:
We appreciate the comments of Dr Jutley
and colleagues concerning our recent arti-
cle.1 As they said, transapical aortic can-
nulation is the most physiologic approach
to establish cardiopulmonary bypass in
type A aortic dissection.
We would like to give some additional
explanation related to their comments. Our
cannula is long enough to traverse the aor-
tic valve in patients with cardiomegaly
(Figure 1, A). It is necessary that our stab
incision, which measures approximately
1 cm, be full-thickness myocardium be-
cause the tip of this cannula is not sharp
(Figure 1, B). As a result, we routinely
close the incision with a few (usually 3) 4-0
polyvinylidene fluoride interrupted sutures
with felt pledgets. There were no bleeding
problems after performing stab-wound can-
nulation and closing the incision with this
technique.
Shinichi Wada, MD
Shin Yamamoto, MD, PhD
Yasuyuki Hosoda, MD
Aortic Center
Kawasaki Saiwai Hospital
Kanagawa, Japan
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Off-pump coronary artery bypass
sacrifices graft patency
To the Editor:
We are grateful to Dr Gardner1 for his
editorial regarding our meta-analysis2 of
randomized controlled trials of off-pump
coronary artery bypass (OPCAB) versus
conventional coronary artery bypass graft-
ing (CABG), and we absolutely agree with
his statement: “the choice of which tech-
nique (of OPCAB or CABG) to use should
remain the surgeon’s option.” However,
we, in the era of evidence-based medicine,
are convinced that the surgeon’s option
should be based on the best evidence, such
as a meta-analysis of randomized con-
trolled trials (type Ia evidence recom-
mended by the Agency for Health Care
Policy and Research).
The meta-analysis of 37 randomized tri-
als (3369 patients) of OPCAB versus
CABG by Cheng and associates,3 pub-
lished in 2005, demonstrated that no sig-
nificant differences were found for 30-day
mortality, myocardial infarction, stroke, re-
nal dysfunction, intraaortic balloon pump,
wound infection, rethoracotomy, or reinter-
vention. However, OPCAB significantly
decreased arterial fibrillation, transfusion,
inotrope requirements, respiratory infec-
tions, ventilation time, intensive care unit
stay, and hospital stay.3 Therefore, OPCAB
Figure 1. Sarns Soft-flow Extended Aortic
Cannula (Terumo Cardiovascular Systems,
Corp, Ann Arbor, Mich).
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